Pricing Log in Create free account

Inovio Pharmaceuticals, Inc. (INO) vs Sutro Biopharma, Inc. (STRO)

Inovio Pharmaceuticals, Inc. and Sutro Biopharma, Inc. are both Biotechnology companies. Inovio Pharmaceuticals, Inc. and Sutro Biopharma, Inc. are of similar size ($167.5M and $164.8M). Inovio Pharmaceuticals, Inc. grew revenue faster over the last twelve months: −54.8% against −56.3%. Inovio Pharmaceuticals, Inc. has the higher net margin (0.00% vs −395.3%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, Inovio Pharmaceuticals, Inc. leads on 8 and Sutro Biopharma, Inc. on 6.

Valuation

Metric INO STRO Biotechnology median
P/E n/m n/m 10.26
P/S 310.99 3.34 9.18
P/B 27.45 n/m 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m 0.03 0.65
EV/Sales 259.00 (0.08) 8.98
Earnings yield (78.57%) (187.89%) (34.89%)
Free cash flow yield (66.73%) (95.31%) (24.52%)

Profitability

Metric INO STRO Biotechnology median
Gross margin 100.00% 100.00% 65.16%
Operating margin 0.00% (319.57%) 0.00%
Net margin 0.00% (395.25%) 0.00%
Free cash flow margin 0.00% (318.63%) 0.00%
Return on equity (409.87%) 266.76% (50.12%)
Return on assets (114.64%) (79.08%) (45.60%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric INO STRO Biotechnology median
Revenue growth (TTM) (54.82%) (56.25%) 6.26%
EPS growth (last fiscal year) 54.18% 24.02% 29.88%
Revenue growth, 5-year CAGR (61.18%) 19.12% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric INO STRO Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.00 3.32 4.89
Net debt to EBITDA 0.70 0.92 1.01

Dividend

Metric INO STRO Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric INO STRO Biotechnology median
Market cap 167.50m 164.82m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack